share_log

JonesTrading Initiates Coverage On TFF Pharmaceuticals With Buy Rating, Announces Price Target of $7

Benzinga ·  Mar 22, 2023 05:10

JonesTrading analyst Justin Walsh initiates coverage on TFF Pharmaceuticals (NASDAQ:TFFP) with a Buy rating and announces Price Target of $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment